Metabolomics advances in chronic atrophic gastritis diagnosis and the integration of traditional Chinese medicine

Chronic atrophic gastritis (CAG) is a prevalent digestive system disorder characterized by the recurrent damage to the gastric mucosal epithelium, with the potential to progress to gastric cancer. Traditional Chinese medicine (TCM), with its holistic perspective and treatment modalities grounded in...

Full description

Saved in:
Bibliographic Details
Main Authors: Yanqun Luo, Haiping Xue, Hongyu Chen, Ying Gao, Guang Ji, Tao Wu
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Saudi Pharmaceutical Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1319016424002640
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846116078432813056
author Yanqun Luo
Haiping Xue
Hongyu Chen
Ying Gao
Guang Ji
Tao Wu
author_facet Yanqun Luo
Haiping Xue
Hongyu Chen
Ying Gao
Guang Ji
Tao Wu
author_sort Yanqun Luo
collection DOAJ
description Chronic atrophic gastritis (CAG) is a prevalent digestive system disorder characterized by the recurrent damage to the gastric mucosal epithelium, with the potential to progress to gastric cancer. Traditional Chinese medicine (TCM), with its holistic perspective and treatment modalities grounded in syndrome differentiation, provides a distinctive approach to both the prevention and treatment of CAG. This review aims to encapsulate the recent advancements in the application of metabolomics to the diagnosis, pathogenesis, and the TCM-based prevention and treatment of CAG, offering novel insights into the therapeutic and preventive strategies for the disease. A systematic analysis was performed on the literature from 2013 to 2024, focusing on studies that utilized metabolomics to investigate the effects of TCM on CAG. The data was sourced from reputable electronic databases including PubMed and Web of Science. The review emphasizes the utility of metabolomics in identifying biomarkers and metabolic pathways associated with CAG and illustrates the capacity of TCM to influence and ameliorate CAG conditions through various mechanisms, including the regulation of gut microbiota and modulation of specific metabolic pathways. This review presents that metabolomics can offer new perspectives for the application of TCM in CAG management, demonstrating significant potential in elucidating the pathogenesis of CAG and in identifying potential therapeutic targets. The convergence of TCM with metabolomics heralds a promising avenue for the personalized treatment of CAG.
format Article
id doaj-art-14e8f66dd7aa4578a4b43c9588c5f17a
institution Kabale University
issn 1319-0164
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series Saudi Pharmaceutical Journal
spelling doaj-art-14e8f66dd7aa4578a4b43c9588c5f17a2024-12-19T10:52:34ZengElsevierSaudi Pharmaceutical Journal1319-01642024-12-013212102213Metabolomics advances in chronic atrophic gastritis diagnosis and the integration of traditional Chinese medicineYanqun Luo0Haiping Xue1Hongyu Chen2Ying Gao3Guang Ji4Tao Wu5Institute of Digestive Disease, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China; Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, ChinaIndustrial Development Center, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, ChinaInstitute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, ChinaInstitute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, ChinaInstitute of Digestive Disease, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China; Corresponding authors at: Institute of Digestive Disease, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, South Wanping Road 725, Shanghai 200032, China.Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; Corresponding authors at: Institute of Digestive Disease, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, South Wanping Road 725, Shanghai 200032, China.Chronic atrophic gastritis (CAG) is a prevalent digestive system disorder characterized by the recurrent damage to the gastric mucosal epithelium, with the potential to progress to gastric cancer. Traditional Chinese medicine (TCM), with its holistic perspective and treatment modalities grounded in syndrome differentiation, provides a distinctive approach to both the prevention and treatment of CAG. This review aims to encapsulate the recent advancements in the application of metabolomics to the diagnosis, pathogenesis, and the TCM-based prevention and treatment of CAG, offering novel insights into the therapeutic and preventive strategies for the disease. A systematic analysis was performed on the literature from 2013 to 2024, focusing on studies that utilized metabolomics to investigate the effects of TCM on CAG. The data was sourced from reputable electronic databases including PubMed and Web of Science. The review emphasizes the utility of metabolomics in identifying biomarkers and metabolic pathways associated with CAG and illustrates the capacity of TCM to influence and ameliorate CAG conditions through various mechanisms, including the regulation of gut microbiota and modulation of specific metabolic pathways. This review presents that metabolomics can offer new perspectives for the application of TCM in CAG management, demonstrating significant potential in elucidating the pathogenesis of CAG and in identifying potential therapeutic targets. The convergence of TCM with metabolomics heralds a promising avenue for the personalized treatment of CAG.http://www.sciencedirect.com/science/article/pii/S1319016424002640Chronic atrophic gastritisMetabolomicsTraditional Chinese medicineDrug monomerGut microbiota
spellingShingle Yanqun Luo
Haiping Xue
Hongyu Chen
Ying Gao
Guang Ji
Tao Wu
Metabolomics advances in chronic atrophic gastritis diagnosis and the integration of traditional Chinese medicine
Saudi Pharmaceutical Journal
Chronic atrophic gastritis
Metabolomics
Traditional Chinese medicine
Drug monomer
Gut microbiota
title Metabolomics advances in chronic atrophic gastritis diagnosis and the integration of traditional Chinese medicine
title_full Metabolomics advances in chronic atrophic gastritis diagnosis and the integration of traditional Chinese medicine
title_fullStr Metabolomics advances in chronic atrophic gastritis diagnosis and the integration of traditional Chinese medicine
title_full_unstemmed Metabolomics advances in chronic atrophic gastritis diagnosis and the integration of traditional Chinese medicine
title_short Metabolomics advances in chronic atrophic gastritis diagnosis and the integration of traditional Chinese medicine
title_sort metabolomics advances in chronic atrophic gastritis diagnosis and the integration of traditional chinese medicine
topic Chronic atrophic gastritis
Metabolomics
Traditional Chinese medicine
Drug monomer
Gut microbiota
url http://www.sciencedirect.com/science/article/pii/S1319016424002640
work_keys_str_mv AT yanqunluo metabolomicsadvancesinchronicatrophicgastritisdiagnosisandtheintegrationoftraditionalchinesemedicine
AT haipingxue metabolomicsadvancesinchronicatrophicgastritisdiagnosisandtheintegrationoftraditionalchinesemedicine
AT hongyuchen metabolomicsadvancesinchronicatrophicgastritisdiagnosisandtheintegrationoftraditionalchinesemedicine
AT yinggao metabolomicsadvancesinchronicatrophicgastritisdiagnosisandtheintegrationoftraditionalchinesemedicine
AT guangji metabolomicsadvancesinchronicatrophicgastritisdiagnosisandtheintegrationoftraditionalchinesemedicine
AT taowu metabolomicsadvancesinchronicatrophicgastritisdiagnosisandtheintegrationoftraditionalchinesemedicine